Modulation of gene expression in formation of fatty atherosclerotic lesions

摘要

Polynucleotides, polypeptides, kits and methods are provided related to genes regulated by the formation of fatty atherosclerotic lesions, and by administration of a dihydropyridine calcium antagonist, lercanidipine.